About Systagenix
Systagenix is a Healthcare company based in Horley (United Kingdom) founded in 2008, and was acquired by Scapa Group in September 2018. Advanced wound therapeutics and regenerative medicine products are developed. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices. Its legal entity is SYSTAGENIX WOUND MANAGEMENT, LIMITED.
Company details
Systagenix was established in 2008 through the acquisition of Johnson Johnsons wound-care business by One Equity Partners, a JPMorgan Chase affiliate. Products are focused on advanced wound therapeutics and regenerative medicine, encompassing antimicrobial solutions, odor management, hydration, granulation promotion, adherence minimization, exudate control, and compression. The company operates from Horley, United Kingdom, and was acquired by Kinetic Concepts for 485 million in 2013.
- Headquarters Horley, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website systagenix.com
- Social LinkedIn X
- Acquired by Scapa Group (Sep 2018)
- Legal Name Systagenix Wound Management, Limited
- Date of Incorporation 27 Aug, 2008
- Jurisdiction BRACKNELL, BERKSHIRE, ENGLAND
- Net Profit-$852.81 (USD)13as on Dec 31, 2015
- InvestorsAcelity
& 1 more
- Acquired by
Investors in Systagenix
Systagenix has secured backing from 2 investors. Prominent investors backing the company include Acelity and Scapa Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Wound therapeutics and regenerative medicine products are developed globally. | 1976 | acelity.com | San Antonio, United States | |
Adhesive-based products for healthcare and industrial sectors are manufactured. | 1927 | scapa.com |
Investor details for Systagenix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Systagenix
3 dated milestones of Systagenix across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Systagenix is founded.
- Exit Acquired by Acelity.
- Exit Acquired by Scapa Group.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Systagenix
Complete news archive for Systagenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Systagenix
Systagenix was founded in 2008.
Systagenix is headquartered in Horley, United Kingdom. It is registered at Horley, Surrey, United Kingdom.
Systagenix was established in 2008 through the acquisition of Johnson Johnsons wound-care business by One Equity Partners, a JPMorgan Chase affiliate. Products are focused on advanced wound therapeutics and regenerative medicine, encompassing antimicrobial solutions, odor management, hydration, granulation promotion, adherence minimization, exudate control, and compression. The company operates from Horley, United Kingdom, and was acquired by Kinetic Concepts for 485 million in 2013.
Systagenix has 2 investors. Key investors include Acelity, and Scapa Group.
Systagenix operates through Systagenix Wound Management, Limited.
Yes. Systagenix was acquired by Scapa Group in September 2018.